Unraveling the Plasma Protein Corona by Ultrasonic Cavitation Augments Active‐Transporting of Liposome in Solid Tumor
- 1 January 2023
- journal article
- research article
- Published by Wiley in Advanced Materials
- Vol. 35 (9) , e2207271
Abstract
Ligand/receptor‐mediated targeted drug delivery has been widely recognized as a promising strategy for improving the clinical efficacy of nanomedicines but is attenuated by the binding of plasma protein on the surface of nanoparticles to form a protein corona. Here, it is shown that ultrasonic cavitation can be used to unravel surface plasma coronas on liposomal nanoparticles through ultrasound (US)‐induced liposomal reassembly. To demonstrate the feasibility and effectiveness of the method, transcytosis‐targeting‐peptide‐decorated reconfigurable liposomes (LPGLs) loaded with gemcitabine (GEM) and perfluoropentane (PFP) are developed for cancer‐targeted therapy. In the blood circulation, the targeting peptides are deactivated by the plasma corona and lose their targeting capability. Once they reach tumor blood vessels, US irradiation induces transformation of the LPGLs from nanodrops into microbubbles via liquid–gas phase transition and decorticate the surface corona by reassembly of the lipid membrane. The activated liposomes regain the capability to recognize the receptors on tumor neovascularization, initiate ligand/receptor‐mediated transcytosis, achieve efficient tumor accumulation and penetration, and lead to potent antitumor activity in multiple tumor models of patient‐derived tumor xenografts. This study presents an effective strategy to tackle the fluid biological barriers of the protein corona and develop transcytosis‐targeting liposomes for active tumor transport and efficient cancer therapy.Keywords
Funding Information
- National Key Research and Development Program of China (2021YFA1201200)
- National Natural Science Foundation of China (82030048, 82102191, 21875211, 52073249, 51833008, 82001818)
This publication has 41 references indexed in Scilit:
- Clinical Application of Radiolabeled RGD Peptides for PET Imaging of Integrin αvβ3Theranostics, 2016
- Passive versus Active Tumor Targeting Using RGD- and NGR-Modified Polymeric NanomedicinesNano Letters, 2014
- Rapid formation of plasma protein corona critically affects nanoparticle pathophysiologyNature Nanotechnology, 2013
- Protein corona significantly reduces active targeting yieldChemical Communications, 2013
- Phase I study of oral CP-4126, a gemcitabine derivative, in patients with advanced solid tumorsInvestigational New Drugs, 2013
- Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surfaceNature Nanotechnology, 2013
- Patient-derived tumour xenografts as models for oncology drug developmentNature Reviews Clinical Oncology, 2012
- Nanoparticle Size and Surface Chemistry Determine Serum Protein Adsorption and Macrophage UptakeJournal of the American Chemical Society, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Transcytosis: Crossing Cellular BarriersPhysiological Reviews, 2003